PulseAGGREGATOR

Home Feed Stories Sources Features

PulseAGGREGATOR

Gathering headlines…

Pulse Aggregator

Your news command center for 10,000+ sources. Search, filter, and set alerts — then cut through the noise with bias analysis, story clustering, and blindspot detection.

Endpoints News

healthCenter

4h ago

Novo Nordisk cans two more trials of IL-6 heart drug for futilitytranslating…

Novo Nordisk has ended work early on two more late-stage studies of its IL-6 inhibitor ziltivekimab after the studies’ data monitoring committee determined there was little chance of them succeeding.

 A spokesperson told Endpoints News ...

Factuality

76/100

Political Bias

Center

Ownership

Endpoints News

Country

USA

Region

North America

Language

English

Keywords#Novo Nordisk#IL-6#health

Read Original ↗ Article view

Comments

Loading comments…

Novo Nordisk cans two more trials of IL-6 heart drug for futility | Pulse Aggregator